Cargando…

Role of the lectin pathway of complement in hematopoietic stem cell transplantation-associated endothelial injury and thrombotic microangiopathy

Hematopoietic stem cell transplantation-associated thrombotic microangiopathy (HSCT-TMA) is a life-threatening syndrome that occurs in adult and pediatric patients after hematopoietic stem cell transplantation. Nonspecific symptoms, heterogeneity within study populations, and variability among curre...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gavriilaki, Eleni, Ho, Vincent T., Schwaeble, Wilhelm, Dudler, Thomas, Daha, Mohamed, Fujita, Teizo, Jodele, Sonata
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8684592/ https://www.ncbi.nlm.nih.gov/pubmed/34924021 http://dx.doi.org/10.1186/s40164-021-00249-8

Ejemplares similares

Peering into the darkness of drug-induced thrombotic microangiopathy: complement, are you in there?
por: Sabulski, Anthony, et al.
Publicado: (2023)

Complement in Thrombotic Microangiopathies: Unraveling Ariadne's Thread Into the Labyrinth of Complement Therapeutics
por: Gavriilaki, Eleni, et al.
Publicado: (2019)

Cerebral vascular injury in transplant-associated thrombotic microangiopathy
por: Sabulski, Anthony, et al.
Publicado: (2022)

Mechanisms of endothelial injury and transplant-associated thrombotic microangiopathy in tandem autologous hematopoietic stem cell transplant for neuroblastoma
por: Sabulski, Anthony, et al.
Publicado: (2023)

An Update in Drug-Induced Thrombotic Microangiopathy
por: Chatzikonstantinou, Thomas, et al.
Publicado: (2020)

Complement Mediated Endothelial Damage in Thrombotic Microangiopathies
por: Blasco, Miquel, et al.
Publicado: (2022)

Absence of the Lectin Activation Pathway of Complement Ameliorates Proteinuria-Induced Renal Injury
por: Alghadban, Samy, et al.
Publicado: (2019)

Complement in Secondary Thrombotic Microangiopathy
por: Palma, Lilian Monteiro Pereira, et al.
Publicado: (2020)

Complement System as a New Target for Hematopoietic Stem Cell Transplantation-Related Thrombotic Microangiopathy
por: Ardissino, Gianluigi, et al.
Publicado: (2022)

Eculizumab precision-dosing algorithm for thrombotic microangiopathy in children and young adults undergoing HSCT
por: Mizuno, Kana, et al.
Publicado: (2022)

Thrombotic microangiopathies assessment: mind the complement
por: Blasco, Miquel, et al.
Publicado: (2020)

Postsurgical Thrombotic Microangiopathy and Deregulated Complement
por: van Herpt, Thijs T. W., et al.
Publicado: (2022)

An updated classification of thrombotic microangiopathies and treatment of complement gene variant-mediated thrombotic microangiopathy
por: Aigner, Christof, et al.
Publicado: (2019)

The Lectin Pathway of Complement Activation Is a Critical Component of the Innate Immune Response to Pneumococcal Infection
por: Ali, Youssif M., et al.
Publicado: (2012)

Endothelial injury and thrombotic microangiopathy in COVID-19: Treatment with the lectin-pathway inhibitor narsoplimab
por: Rambaldi, Alessandro, et al.
Publicado: (2020)

Exploring the role of the complement system, endothelial injury, and microRNAs in thrombotic microangiopathy after kidney transplantation
por: Aleš Rigler, Andreja, et al.
Publicado: (2020)

Complement, thrombotic microangiopathy and disseminated intravascular coagulation
por: Kurosawa, Shinichiro, et al.
Publicado: (2014)

Decreased Levels of Soluble Developmental Endothelial Locus-1 Are Associated with Thrombotic Microangiopathy in Pregnancy
por: Romanidou, Gioulia, et al.
Publicado: (2023)

Mannan binding lectin-associated serine protease-2 (MASP-2) critically contributes to post-ischemic brain injury independent of MASP-1
por: Orsini, Franca, et al.
Publicado: (2016)

Lectin Pathway Mediates Complement Activation by SARS-CoV-2 Proteins
por: Ali, Youssif M., et al.
Publicado: (2021)

Thrombotic microangiopathy mediates poor prognosis among lupus nephritis via complement lectin and alternative pathway activation
por: Zhang, Binshan, et al.
Publicado: (2022)

The Contribution of Complement to the Pathogenesis of IgA Nephropathy: Are Complement-Targeted Therapies Moving from Rare Disorders to More Common Diseases?
por: Poppelaars, Felix, et al.
Publicado: (2021)

Pregnancies in kidney transplant recipients with complement gene variant-mediated thrombotic microangiopathy
por: Haninger-Vacariu, Natalja, et al.
Publicado: (2020)

Thinking Beyond HLH: Clinical Features of Patients with Concurrent Presentation of Hemophagocytic Lymphohistiocytosis and Thrombotic Microangiopathy
por: Gloude, Nicholas J., et al.
Publicado: (2020)

Extra-Renal Manifestations of Complement-Mediated Thrombotic Microangiopathies
por: Hofer, Johannes, et al.
Publicado: (2014)

The potential role of complements in cocaine-induced thrombotic microangiopathy
por: Dejman, Adriana, et al.
Publicado: (2018)

Variable clinical manifestations of hematopoietic stem cell transplant‐associated thrombotic microangiopathy
por: Jia, Chenguang, et al.
Publicado: (2019)

Coagulopathy, endothelial dysfunction, thrombotic microangiopathy and complement activation: potential role of complement system inhibition in COVID-19
por: Wang, Xin, et al.
Publicado: (2020)

Endothelial and Complement Activation As Predictors of Survival in Adult Allogeneic Hematopoietic Cell Transplantation
por: Gavriilaki, Eleni, et al.
Publicado: (2020)

Tackling COVID‐19 infection through complement‐targeted immunotherapy
por: Jodele, Sonata, et al.
Publicado: (2020)

Genetic and Functional Evidence of Complement Dysregulation in Multiple Myeloma Patients with Carfilzomib-Induced Thrombotic Microangiopathy Compared to Controls
por: Gavriilaki, Eleni, et al.
Publicado: (2022)

Narsoplimab, a Mannan-Binding Lectin-Associated Serine Protease-2 Inhibitor, for the Treatment of Adult Hematopoietic Stem-Cell Transplantation–Associated Thrombotic Microangiopathy
por: Khaled, Samer K., et al.
Publicado: (2022)

Hematopoietic cell transplantation-associated thrombotic microangiopathy: a review of pathophysiology, diagnosis, and treatment
por: Rosenthal, Joseph
Publicado: (2016)

Therapeutic Complement Targeting in ANCA-Associated Vasculitides and Thrombotic Microangiopathy
por: Novikov, Pavel, et al.
Publicado: (2016)

Eculizumab for complement mediated thrombotic microangiopathy in sickle cell disease
por: Chonat, Satheesh, et al.
Publicado: (2020)

The Syndromes of Thrombotic Microangiopathy: A Critical Appraisal on Complement Dysregulation
por: Timmermans, Sjoerd A. M. E. G., et al.
Publicado: (2021)

Complement-Mediated Thrombotic Microangiopathy in Pregnancy: An Educational Case Report
por: Bruno, Valentina, et al.
Publicado: (2023)

Pregnancy in Complement-Mediated Thrombotic Microangiopathy: Maternal and Neonatal Outcomes
por: Haninger-Vacariu, Natalja, et al.
Publicado: (2023)

Early Elevation of Complement Factor Ba Is a Predictive Biomarker for Transplant-Associated Thrombotic Microangiopathy
por: Okamura, Hiroshi, et al.
Publicado: (2021)

Transplant-Associated Thrombotic Microangiopathy in the Context of Allogenic Hematopoietic Stem Cell Transplantation: Where We Stand
por: Lazana, Ioanna
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_npqfijlobvhf8n45g4e27ls6nq